Evidence map›Paper›PMID 38396174›Full record

ArticleGenes and immunity2024

Cytokine profiling and transcriptomics in mononuclear cells define immune variants in Meniere Disease.

Marisa Flook, Elena Rojano, Alvaro Gallego-Martinez, Alba Escalera-Balsera, Patricia Perez-Carpena, M Del Carmen Moleon, Rocio Gonzalez-Aguado, Victoria Rivero de Jesus, Emilio Domínguez-Durán, Lidia Frejo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Genes and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. A Systematic Review on the Role of the Stria Vascularis in Menière's Disease Pathogenesis.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Pooled it
  2. Review
  3. ZDHHC5 may regulate the function of NKT cells and the immune response in Meniere's disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Whole genome DNA methylation profiles define Meniere's disease subclusters.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Immunological mechanisms in Meniere's disease.Frontiers in immunology · 2025
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Marisa FlookOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain. marisa.pereira@ucl.ac.uk.ORCID 0000-0002-2695-0739
Elena RojanoDepartment of Molecular Biology and Biochemistry, Faculty of Sciences, University of Malaga, Malaga, Spain.
Alvaro Gallego-MartinezOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain.ORCID 0000-0002-6068-8965
Alba Escalera-BalseraOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain.ORCID 0000-0003-1027-8594
Patricia Perez-CarpenaOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain.
M Del Carmen MoleonSensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, CIBERER, Madrid, Spain.
Rocio Gonzalez-AguadoDepartment of Otorhinolaryngology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
Victoria Rivero de JesusHospital Clínic, Department of Otorhinolaryngology, Barcelona, Spain.
Emilio Domínguez-DuránUnidad de Gestión Clínica de Otorrinolaringología, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Lidia FrejoOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain.
Juan A G RaneaDepartment of Molecular Biology and Biochemistry, Faculty of Sciences, University of Malaga, Malaga, Spain.
Jose Antonio Lopez-EscamezOtology and Neurotology Group CTS495, Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Universidad de Granada, Granada, Spain. jose.lopezescamez@sydney.edu.au.ORCID 0000-0002-8583-1430
Universidad de Granada · ESThe University of Sydney · AUCentre for Biomedical Network Research on Rare Diseases · ESHospital Clínic de Barcelona · ESHospital Universitario Virgen Macarena · ESInstituto de Investigación Biomédica de Málaga · ESInstituto Nacional de Técnica Aeroespacial · ESMarqués de Valdecilla University Hospital · ES

Funding

Consejería de Salud, Junta de Andalucía (Ministry of Health, Andalusian Regional Government) DOC_01677Consejería de Salud, Junta de Andalucía (Ministry of Health, Andalusian Regional Government) RH-0079-2021EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) 101080580Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) CD20/0153Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) F18/00228Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) IMP/00019Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) IMP00019Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI17/1644Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI20-1126Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PID2019-108096RB-C21Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PID2022-140047OB-C21
6 · The paper itself

Abstract

Meniere Disease (MD) is a chronic inner ear disorder characterized by vertigo attacks, sensorineural hearing loss, tinnitus, and aural fullness. Extensive evidence supporting the inflammatory etiology of MD has been found, therefore, by using transcriptome analysis, we aim to describe the inflammatory variants of MD. We performed Bulk RNAseq on 45 patients with definite MD and 15 healthy controls. MD patients were classified according to their basal levels of IL-1β into 2 groups: high and low. Differentially expression analysis was performed using the ExpHunter Suite, and cell type proportion was evaluated using the estimation algorithms xCell, ABIS, and CIBERSORTx. MD patients showed 15 differentially expressed genes (DEG) compared to controls. The top DEGs include IGHG1 (p = 1.64

Indexed as

Meniere DiseaseCD8-Positive T-LymphocytesGene Expression ProfilingHumansInterleukin-6Leukocytes, MononuclearInterleukin-6

Identifiers

PMID38396174
PMCPMC11023934
OpenAlexW4392122468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.